Article: Aurobindo Pharma gets USFDA nod for anti-depressant drug.

Aurobindo Pharma gets USFDA nod for anti-depressant drug

Mumbai, Mar 4 (PTI) Drug-maker Aurobindo Pharma today said it has received tentative approval from the US drug regulator for anti-depressant tablets Escitalopram Oxalate.

In a filing with the Bombay Stock Exchange, Aurobindo Pharma said it got tentative approval from the US Food and Drug Administration (USFDA) for Escitalopram Oxalate tablets.

...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!